TheraRadar
← Back
Data updated: Mar 29, 2026

SPIL

CardiovascularInfectious Disease
Pharma

SPIL is a pharmaceutical company focused on Cardiovascular, Infectious Disease. Key products include KAPSPARGO SPRINKLE.

2018
Since
5
Drugs
-
Trials
9
Approved (2yr)

Key Drugs

KAPSPARGO SPRINKLE
metoprolol succinate
Cardiovascular
Beta-1 adrenergic receptor 3 indications · 2018

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

OMEPRAZOLE MAGNESIUM 2025-08-07
AMPHOTERICIN B 2025-06-30
OMEPRAZOLE MAGNESIUM 2025-06-05
Manufacturing (CMC)
AMPHOTERICIN B 2025-06-02
OMEPRAZOLE MAGNESIUM 2024-11-08
Labeling
OMEPRAZOLE MAGNESIUM 2024-11-08
Labeling
OMEPRAZOLE MAGNESIUM 2024-11-08
Labeling
OMEPRAZOLE MAGNESIUM 2024-11-08
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 67%
2 drugs
Infectious Disease 33%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Merck big-pharma
Infectious Disease, Cardiovascular
Baxter specialty
Infectious Disease, Cardiovascular
Johnson & Johnson big-pharma
Infectious Disease, Cardiovascular
B BRAUN specialty
Infectious Disease, Cardiovascular
COSETTE other
Cardiovascular, Infectious Disease